Joel Palefsky, MD
Enriched profileProfessor of Medicine, Division of Infectious Diseases, UCSF School of Medicine · University of California, San Francisco
Joel Palefsky is Professor of Medicine, Division of Infectious Diseases, UCSF School of Medicine at University of California, San Francisco. OpenAlex indexes 561 publications with 39,245 citations (h-index 100); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 8 Oct 2026
Overview
Updated 14 Oct 2026
Joel Palefsky, MD, is Professor of Medicine, Division of Infectious Diseases, UCSF School of Medicine at University of California, San Francisco. The public record shows 561 publications with 39,245 citations (h-index 100), centered on Cervical Cancer and HPV Research, Colorectal and Anal Carcinomas, Viral-associated cancers and disorders. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 8 companies, 21 NIH-funded awards (1991–2025).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: Cervical Cancer and HPV Research
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 339.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Sponsor: University of California, San Francisco
- Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
Sponsor: University of California, San Francisco
- People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Sponsor: University of California, San Francisco
Industry payments
Updated 14 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202522 payments$22,119openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20241 payment
NIH funding
Updated 14 Oct 2026
21 NIH research awards on record, funded 1991–2025 per NIH RePORTER. The latest:
- CAMPO consortium: HPV-related anogenital disease in people with HIV
University of California, San Francisco
FY2025$369,648U54CA242646 - CAMPO Administrative and Coordinating Core
University of California, San Francisco
FY2025$253,564U54CA242646 - California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
University of California, San Francisco
FY2025$113,778U54CA242646
Congress activity
Updated 14 Oct 2026
6 congress contributions (2011–2018) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Long-term effectiveness and immunogenicity of quadrivalent HPV vaccine in young men: 10-year end-of study analysis.
ASCO Annual Meeting
ASCO2018Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men.
Clinical infectious diseases
Clinical Trial2026 - High Risk of Incident-Persistent Human Papillomavirus Infection With 9-Valent Vaccine Types in Young Men With an HPV Infection.
Open forum infectious diseases
Article2026 - Assessment of Concordant Human Papillomavirus Infection With 9-Valent Vaccine Types Across Anogenital Sites in Young Men.
The Journal of infectious diseases
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityArticle4,660 citations2018
- 02Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesArticle1,153 citations2011
- 03
- 04HPV Vaccine against Anal HPV Infection and Anal Intraepithelial NeoplasiaArticle949 citations2011
- 05The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated LesionsArticle581 citations2012
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- FRCP(C)
Fellow of the Royal College of Physicians of Canada
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- Founder and Past President
International Anal Neoplasia Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Past President
International Papillomavirus Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Vice-chair
AIDS Malignancy Consortium (NCI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Founder and chairperson
IPVS International HPV Awareness Campaign
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Anal Neoplasia Clinic, Research and Education Center, UCSF Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Owen Wolkowitz, MD
University of California, San Francisco
Emily Bergsland, MD
University of California, San Francisco
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute